Algernon NeuroScience Announces 40 Patient Phase 2 Psychedelic Drug DMT Stroke...

Psychedelic Neuroscience Demystified: How Psychedelics Alter Consciousness and Produce Therapeutic Effects

MIND CURE ANNOUNCES CLOSING OF LNG ENERGY’S SUBSCRIPTION RECEIPT FINANCING

Navigating Psychedelics: Jewish-Informed Perspectives on Psychedelics

PT429 – From Mycophobia to Fungi Fever: The Psychedelic Space’s Growing...

Natural Medicine Advisory Bulletin #2: July 2023

COMPASS Pathways Announces Second Quarter 2023 Financial Results and Business Highlights  

Breathwork Explainer and Q+A

Across the Threshold: A Fireside on NDE’s with Psychedelics Today

Psyence Group Announces SEC Registration Filing with NASDAQ SPAC, Newcourt, and Signing...

Load more